- Press Release -

Rockville, Md. The global market for over-the-counter vitamins and dietary supplements is set to surpass US$ 97.688 Bn by 2022, expanding at a 6.7% CAGR, according to Fact.MR. Sold without a prescription and regulated for safety, these products have moved from occasional purchase to daily habit as more consumers take charge of their own health.

General well-being is the main reason people buy, pharmacies remain the dominant point of sale, and capsules lead the format mix. North America carries the highest value share, while growth in emerging markets is widening the customer base.

Functions, Channels and Formats

Most demand is tied to general well-being rather than specific conditions, and that segment accounts for a large slice of revenue. Pharmacies stay the top OTC channel at more than a quarter of value, though the release notes the channel is expected to cede a small share as online retail and modern trade expand. By format, capsules remain strong and are set to reach around US$ 32.891 Bn by 2022, helped by easy dosing and broad consumer familiarity.

North America holds the highest value share, supported by rising OTC drug demand in the United States, Europe accounts for more than 31% of value by 2017, and Asia Pacific excluding Japan is emerging as an attractive market as awareness grows in China, India and Brazil.

Self-Care Reshapes Demand

The market's momentum is rooted in behaviour. As self-treatment becomes normal and consumers weigh convenience and cost, direct purchase of vitamins and supplements keeps rising. Manufacturers are responding with more advanced formulations aimed at improving how well these products work, reinforcing the shift.

Suppliers and Their Playbook

The field spans pharmaceutical, nutrition and ingredient companies.

• Dil Limited., Bactolac Pharmaceutical, Inc., Otsuka Holdings Co. Ltd., CSPC Pharmaceutical Group Limited., Reckitt Benckiser LLC, Sanofi S.A., Pfizer, Inc., Atrium Innovations, Inc., Lonza Group Ltd, Jubilant Life Sciences Limited, Archer Daniels Midland Company, Koninklijke DSM N.V., BASF SE, GlaxoSmithKline plc and DuPont are among the key players in the report.

Reading the Market for Decisions

For manufacturers, the pull toward general well-being and capsules points to where to focus, while the rise of online channels signals where distribution is heading. Investors get a large market driven by durable self-care demand. Procurement and retail teams can plan around pharmacies leading distribution today, capsules carrying volume, and North America offering the largest opportunity through 2022.

About the Report

Fact.MR's study covers the global OTC vitamins and dietary supplements market for the 2017 to 2022 forecast period, with segmentation by function, distribution channel, form and region. It sizes each segment, maps the competitive field, and weighs the consumer forces shaping demand. Further detail is available in the OTC vitamins and dietary supplements market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.